rs727505371
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_023110.3(FGFR1):c.1037_1038delCT(p.Ser346fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
FGFR1
NM_023110.3 frameshift
NM_023110.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
FGFR1 (HGNC:3688): (fibroblast growth factor receptor 1) The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene have been associated with Pfeiffer syndrome, Jackson-Weiss syndrome, Antley-Bixler syndrome, osteoglophonic dysplasia, and autosomal dominant Kallmann syndrome 2. Chromosomal aberrations involving this gene are associated with stem cell myeloproliferative disorder and stem cell leukemia lymphoma syndrome. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-38421839-TAG-T is Pathogenic according to our data. Variant chr8-38421839-TAG-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 180154.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-38421839-TAG-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR1 | ENST00000447712.7 | c.1037_1038delCT | p.Ser346fs | frameshift_variant | 8/18 | 1 | NM_023110.3 | ENSP00000400162.2 | ||
FGFR1 | ENST00000397091.9 | c.1031_1032delCT | p.Ser344fs | frameshift_variant | 8/18 | 1 | ENSP00000380280.5 | |||
FGFR1 | ENST00000397108.8 | c.1031_1032delCT | p.Ser344fs | frameshift_variant | 9/19 | 1 | ENSP00000380297.4 | |||
FGFR1 | ENST00000397113.6 | c.1031_1032delCT | p.Ser344fs | frameshift_variant | 8/18 | 2 | ENSP00000380302.2 | |||
FGFR1 | ENST00000356207.9 | c.770_771delCT | p.Ser257fs | frameshift_variant | 7/17 | 1 | ENSP00000348537.5 | |||
FGFR1 | ENST00000326324.10 | c.764_765delCT | p.Ser255fs | frameshift_variant | 7/17 | 1 | ENSP00000327229.6 | |||
FGFR1 | ENST00000397103.5 | c.814+1184_814+1185delCT | intron_variant | 5 | ENSP00000380292.1 | |||||
FGFR1 | ENST00000487647.5 | n.*728_*729delCT | non_coding_transcript_exon_variant | 7/12 | 1 | ENSP00000435254.1 | ||||
FGFR1 | ENST00000487647.5 | n.*728_*729delCT | 3_prime_UTR_variant | 7/12 | 1 | ENSP00000435254.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249924Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135550
GnomAD3 exomes
AF:
AC:
1
AN:
249924
Hom.:
AF XY:
AC XY:
1
AN XY:
135550
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461886Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 727244
GnomAD4 exome
AF:
AC:
1
AN:
1461886
Hom.:
AF XY:
AC XY:
1
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypogonadotropic hypogonadism 7 with or without anosmia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | case-control | Chan Lab, Boston Children's Hospital | Nov 01, 2014 | - - |
Delayed puberty Pathogenic:1
Likely pathogenic, criteria provided, single submitter | case-control | Chan Lab, Boston Children's Hospital | Nov 01, 2014 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 22, 2024 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33384420, 33775534, 23533228, 36407308, 36268624) - |
Pfeiffer syndrome;C1563720:Hypogonadotropic hypogonadism 2 with or without anosmia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 07, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 180154). This premature translational stop signal has been observed in individual(s) with Kallman syndrome (PMID: 23533228). This variant is present in population databases (rs727505371, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Ser346Tyrfs*61) in the FGFR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FGFR1 are known to be pathogenic (PMID: 12627230). - |
Hypogonadotropic hypogonadism 2 with or without anosmia Uncertain:1
Uncertain significance, flagged submission | research | Reproductive Endocrine Unit, Massachusetts General Hospital | May 04, 2023 | The variant NM_023110.2:c.1037_1038del, p.(Ser346Tyrfs*61) het has been classified as VUS based on the variant meeting the following ACMG Criteria: PVS1,PP3. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 9
Find out detailed SpliceAI scores and Pangolin per-transcript scores at